Debevoise Advises Sumitomo and Sawai in the $210 Million Sale of Upsher-Smith to Bora Pharmaceuticals

17 January 2024

Debevoise & Plimpton LLP is advising Sawai Group Holdings and Sumitomo Corporation of Americas in the $210 million sale of their subsidiary Upsher-Smith Laboratories to Bora Pharmaceuticals. For more information, please see the company’s press release.

The Debevoise team is led by M&A partner Andrew Bab and includes associates Tiancheng (TC) Huang, Shira Huberfeld, Andrew Lee, Hannah Levine, Grace Li  and Tanaya Sanyal, employee benefits and executive compensation associates Matthew Ryan and Wendy Widman, tax partners Rafael Kariyev and Peter Schuur and associate Kimberly Lee, intellectual property partner Henry Lebowitz and associate Luis Sanchez, FDA regulatory partner Paul Rubin and counsel Melissa Runsten, M&A counsel Kim Le, and restructuring partners Natasha Labovitz and Sidney Levinson.